Evidence map›Paper›PMID 23552370›Full record

ArticleScience translational medicine2013

Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.

Michael P Kurnellas, Chris M Adams, Raymond A Sobel, Lawrence Steinman, Jonathan B Rothbard

Abstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Multiple Sclerosis: Inflammatory and Neuroglial Aspects.Current issues in molecular biology · 2023
    Review
  6. Article
  7. Antipsychotics, versatility in action.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. The role of wild-type tau in Alzheimer's disease and related tauopathies.Journal of life sciences (Westlake Village, Calif.) · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregation.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  13. Systematic Review of Basic Research on Alzheimer's Disease with Shen Zhi Ling Oral Liquid.Evidence-based complementary and alternative medicine : eCAM · 2019
    Review
  14. Review
  15. Identification of a common immune regulatory pathway induced by small heat shock proteins, amyloid fibrils, and nicotine.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Recombination and identification of human alpha B-crystallin.International journal of ophthalmology · 2018
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael P KurnellasDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5316, USA.
Chris M Adams
Raymond A Sobel
Lawrence Steinman
Jonathan B Rothbard
Stanford University · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Immunoregulation of AutoimmunityU01DK078123 · NIDDK · STANFORD UNIVERSITY · PI FATHMAN, CHARLES GARRISON · 2006 to 2011
$1.9M
The Generation and Maintenance of Human Memory B Cells Z01AI000949 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PIERCE, SUSAN · 2004 to 2008
$1.8M
Autoantibody Arrays Guide Tolergenic Therapy for Multiple SclerosisR01NS055997 · NINDS · STANFORD UNIVERSITY · PI STEINMAN, LAWRENCE · 2008 to 2012
$1.6M
Intramural NIH HHS Z01 AI000949NIAID NIH HHS 1R43AI0949NIAID NIH HHS T32 AI007290NIDDK NIH HHS U01 DK078123NIDDK NIH HHS UO1DK078123NINDS NIH HHS R01 NS055997NINDS NIH HHS R01NS55997
6 · The paper itself

Abstract

The amyloid-forming proteins tau, αB crystallin, and amyloid P protein are all found in lesions of multiple sclerosis (MS). Our previous work established that amyloidogenic peptides from the small heat shock protein αB crystallin (HspB5) and from amyloid β fibrils, characteristic of Alzheimer's disease, were therapeutic in experimental autoimmune encephalomyelitis (EAE), reflecting aspects of the pathology of MS. To understand the molecular basis for the therapeutic effect, we showed a set of amyloidogenic peptides composed of six amino acids, including those from tau, amyloid β A4, major prion protein (PrP), HspB5, amylin, serum amyloid P, and insulin B chain, to be anti-inflammatory and capable of reducing serological levels of interleukin-6 and attenuating paralysis in EAE. The chaperone function of the fibrils correlates with the therapeutic outcome. Fibrils composed of tau 623-628 precipitated 49 plasma proteins, including apolipoprotein B-100, clusterin, transthyretin, and complement C3, supporting the hypothesis that the fibrils are active biological agents. Amyloid fibrils thus may provide benefit in MS and other neuroinflammatory disorders.

Indexed as

Protein MultimerizationAmino Acid SequenceAmyloidAnimalsBenzothiazolesBiotinylationBlood ProteinsChemical PrecipitationEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansHydrogen-Ion ConcentrationInflammationInterleukin-6MiceMice, Inbred C57BLAmyloidBenzothiazolesBlood ProteinsInterleukin-6Molecular ChaperonesPeptidesThiazolesthioflavin T

Identifiers

PMID23552370
PMCPMC3684024
OpenAlexW2157909659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.